Skip to main content
Fig. 3 | Allergy, Asthma & Clinical Immunology

Fig. 3

From: Predictive significance of arachidonate 15-lipoxygenase for eosinophilic chronic rhinosinusitis with nasal polyps

Fig. 3

Comparison of the demographic characteristics between the high combination level group and the low combination level group, divided according to the predictive cut-off value. a number of ECRSwNP patients (black columns) / nonECRSwNP patients (grey columns), b sex (black columns for female, grey columns for male), c age, d previous surgery, e comorbid asthma, f comorbid allergic rhinitis, and g comorbid atopy (d-g, black columns for yes and grey columns for no for other characteristics). ECRSwNP eosinophilic chronic rhinosinusitis with nasal polyps, nonECRSwNP non-eosinophilic chronic rhinosinusitis with nasal polyps. The combination represents arachidonate 15-lipoxygenase with blood eosinophils

Back to article page